Page 15 - An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression

SCIENCE ADVANCES | RESEARCH ARTICLE

(BioLegend, catalog number 117318), anti-CD80–FITC (BioLegend, 14. X. W. Wang, X. Y. Zhong, F. Gong, Y. Chao, L. Cheng, Newly developed strategies
catalog number 104706), and anti-CD86–allophycocyanin (BioLegend, for improving sonodynamic therapy. Mater. Horizons 7, 2028–2046 (2020).
catalog number 105012) and analyzed by FCM (Thermo Fisher Sci- 15. W. Yue, L. Chen, L. Yu, B. Zhou, H. Yin, W. Ren, C. Liu, L. Guo, Y. Zhang, L. Sun, K. Zhang,
entific, Attune NxT). H. Xu, Y. Chen, Checkpoint blockade and nanosonosensitizer-augmented noninvasive
sonodynamic therapy combination reduces tumour growth and metastases in mice.
To systematically investigate the in vivo antitumor immune re- Nat. Commun. 10, 2025 (2019).
sponses against tumor metastasis, suspensions in tumors were stained 16. Q. Zhang, C. Bao, X. Cai, L. Jin, L. Sun, Y. Lang, L. Li, Sonodynamic therapy-assisted
with anti-CD3–PE (BioLegend, catalog number 100308), anti- immunotherapy: A novel modality for cancer treatment. Cancer Sci. 109, 1330–1345
CD8a–PerCP (BioLegend, catalog number 100732), and anti-CD4– (2018).
allophycocyanin (BioLegend, catalog number 100412) antibodies. 17. J. Ouyang, Z. Tang, N. Farokhzad, N. Kong, N. Y. Kim, C. Feng, S. Blake, Y. Xiao, C. Liu, T. Xie,
W. Tao, Ultrasound mediated therapy: Recent progress and challenges in nanoscience.
To further analyze T cells in spleens, cells were stained with anti- Nano Today 35, 100949 (2020).
CD3–PE (BioLegend, catalog number 100308), anti-CD8a–PerCP 18. A. L. Harvey, R. Edrada-Ebel, R. J. Quinn, The re-emergence of natural products for drug
(peridinin chlorophyll protein) (BioLegend, catalog number 100732), discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111–129 (2015).
anti-CD4–allophycocyanin (BioLegend, catalog number 100412), 19. F. Qu, P. Wang, K. Zhang, Y. Shi, Y. Li, C. Li, J. Lu, Q. Liu, X. Wang, Manipulation
of mitophagy by “All-in-One” nanosensitizer augments sonodynamic glioma therapy.
anti-CD44–FITC (BioLegend, catalog number 103006), or anti-CD69– Autophagy 16, 1413–1435 (2020).
FITC (BioLegend, catalog number 104506). All these antibodies used 20. H. Shi, Q. Liu, X. Qin, P. Wang, X. Wang, Pharmacokinetic study of a novel sonosensitizer
in our experiments were in a 1:100 dilution from the stock solutions. chlorin-e6 and its sonodynamic anti-cancer activity in hepatoma-22 tumor-bearing mice.
Biopharm. Drug Dispos. 32, 319–332 (2011).
Statistical analysis 21. H. Wang, Q. Liu, K. Zhang, P. Wang, Q. Xue, L. Li, X. Wang, Comparison between
sonodynamic and photodynamic effect on MDA-MB-231 cells. J. Photochem. Photobiol. B
Statistical analysis was performed by GraphPad Prism 8 using one- Biol. 127, 182–191 (2013).
way analysis of variance (ANOVA), two-way ANOVA, or Student’s 22. B. Chen, R. Zheng, D. Liu, B. Li, J. Lin, W. Zhang, The tumor affinity of chlorin e6 and its
t test. The specific statistical test performed for each experiment was sonodynamic effects on non-small cell lung cancer. Ultrason. Sonochem. 20, 667–673
(2013).
included in the corresponding figure legends. Asterisks represent 23. P. Zhu, Y. Chen, J. Shi, Nanoenzyme-augmented cancer sonodynamic therapy by
different levels of significance: *P < 0.05, **P < 0.01, ***P < 0.001, catalytic tumor oxygenation. ACS Nano 12, 3780–3795 (2018).
and ****P < 0.0001; ns, not significant. All of the flow cytometry 24. S. Wang, E. Bromley, L. Xu, J. C. Chen, L. Keltner, Talaporfin sodium. Expert Opin.
analyses were performed using FlowJo 10. Pharmacother. 11, 133–140 (2010).
25. Y. Dong, G. Li, L. Wang, L. Cao, Y. Li, W. Zhao, Anti-tumor evaluation of a novel
SUPPLEMENTARY MATERIALS methoxyphenyl substituted chlorin photosensitizer for photodynamic therapy.
J. Photochem. Photobiol. B Biol. 211, 112015 (2020).
Supplementary material for this article is available at https://science.org/doi/10.1126/ 26. L. Cao, X. Guo, L. Wang, S. Wang, Y. Li, W. Zhao, Synthesis and in vitro phototoxicity
sciadv.abj4796 of novel -extension derivatives of chlorin e6. New J. Chem. 41, 14279–14287 (2017).
View/request a protocol for this paper from Bio-protocol. 27. Y. Lv, J. Zheng, Q. Zhou, L. Jia, C. Wang, N. Liu, H. Zhao, H. Ji, B. Li, W. Cao, Antiproliferative
and apoptosis-inducing effect of exo-protoporphyrin IX based sonodynamic therapy
REFERENCES AND NOTES on human oral squamous cell carcinoma. Sci. Rep. 7, 40967 (2017).
28. S. Shen, L. Wu, J. Liu, M. Xie, H. Shen, X. Qi, Y. Yan, Y. Ge, Y. Jin, Core-shell structured
1. K. Y. Helmy, S. A. Patel, G. R. Nahas, P. Rameshwar, Cancer immunotherapy:
Fe 3O 4@TiO 2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy Downloaded from https://www.science.org at Dalian University of Technology on October 20, 2021
Accomplishments to date and future promise. Ther. Deliv. 4, 1307–1320 (2013).
of cancer. Int. J. Pharm. 486, 380–388 (2015).
2. S. A. Eccles, D. R. Welch, Metastasis: Recent discoveries and novel treatment strategies.
29. N. Yumita, Y. Iwase, K. Nishi, T. Ikeda, H. Komatsu, T. Fukai, K. Onodera, H. Nishi, K. Takeda,
Lancet 369, 1742–1757 (2007).
S.-I. Umemura, K. Okudaira, Y. Momose, Sonodynamically-induced antitumor effect
3. K. Shao, S. Singha, X. Clemente-Casares, S. Tsai, Y. Yang, P. Santamaria, Nanoparticle-
of mono-l-aspartyl chlorin e6 (NPe6). Anticancer Res. 31, 501–506 (2011).
based immunotherapy for cancer. ACS Nano 9, 16–30 (2015).
30. N. Yumita, Y. Iwase, K. Nishi, T. Ikeda, S.-I. Umemura, I. Sakata, Y. Momose,
4. S. Singha, K. Shao, K. K. Ellestad, Y. Yang, P. Santamaria, Nanoparticles for immune
Sonodynamically induced cell damage and membrane lipid peroxidation by novel
stimulation against infection, cancer, and autoimmunity. ACS Nano 12, 10621–10635
porphyrin derivative, DCPH-P-Na(I). Anticancer Res. 30, 2241–2246 (2010).
(2018).
31. T. Osaki, I. Yokoe, Y. Uto, M. Ishizuka, T. Tanaka, N. Yamanaka, T. Kurahashi, K. Azuma,
5. Z. Zhao, A. Ukidve, V. Krishnan, A. Fehnel, D. C. Pan, Y. Gao, J. Kim, M. A. Evans, A. Mandal,
Y. Murahata, T. Tsuka, N. Ito, T. Imagawa, Y. Okamoto, Bleomycin enhances the efficacy
J. Guo, V. R. Muzykantov, S. Mitragotri, Systemic tumour suppression via the preferential of sonodynamic therapy using aluminum phthalocyanine disulfonate. Ultrason.
accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung
Sonochem. 28, 161–168 (2016).
metastases. Nat. Biomed. Eng. 5, 441–454 (2021).
32. W. Secomski, K. Bilmin, T. Kujawska, A. Nowicki, P. Grieb, P. A. Lewin, In vitro ultrasound
6. X. Lin, J. Song, X. Chen, H. Yang, Ultrasound-activated sensitizers and applications.
experiments: Standing wave and multiple reflections influence on the outcome.
Angew. Chem. Int. Ed. Engl. 59, 14212–14233 (2020).
Ultrasonics 77, 203–213 (2017).
7. K. Zhang, H. Xu, H. Chen, X. Jia, S. Zheng, X. Cai, R. Wang, J. Mou, Y. Zheng, J. Shi, CO2
bubbling-based ‘Nanobomb’ system for targetedly suppressing Panc-1 pancreatic tumor 33. D. M. Rubin, N. Anderton, C. Smalberger, J. Polliack, M. Nathan, M. Postema, On
via low intensity ultrasound-activated inertial cavitation. Theranostics 5, 1291–1302 the behaviour of living cells under the influence of ultrasound. Fluids 3, 82 (2018).
(2015). 34. M. Niedre, M. S. Patterson, B. C. Wilson, Direct near-infrared luminescence detection
8. N. Yumita, R. Nishigaki, K. Umemura, S. Umemura, Hematoporphyrin as a sensitizer of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo.
of cell-damaging effect of ultrasound. Jpn. J. Cancer Res. 80, 219–222 (1989). Photochem. Photobiol. 75, 382–391 (2002).
9. S. Umemura, N. Yumita, R. Nishigaki, K. Umemura, Mechanism of cell damage by 35. G. Kroemer, L. Galluzzi, O. Kepp, L. Zitvogel, Immunogenic cell death in cancer therapy.
ultrasound in combination with hematoporphyrin. Jpn. J. Cancer Res. 81, 962–966 (1990). Annu. Rev. Immunol. 31, 51–72 (2013).
10. S. Son, J. H. Kim, X. Wang, C. Zhang, S. A. Yoon, J. Shin, A. Sharma, M. H. Lee, L. Cheng, 36. L. Aymeric, L. Apetoh, F. Ghiringhelli, A. Tesniere, I. Martins, G. Kroemer, M. J. Smyth,
J. Wu, J. S. Kim, Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem. L. Zitvogel, Tumor cell death and ATP release prime dendritic cells and efficient
Soc. Rev. 49, 3244–3261 (2020). anticancer immunity. Cancer Res. 70, 855–858 (2010).
11. H. Zhao, B. Zhao, L. Li, K. Ding, H. Xiao, C. Zheng, L. Sun, Z. Zhang, L. Wang, Biomimetic 37. A. D. Garg, D. V. Krysko, T. Verfaillie, A. Kaczmarek, G. B. Ferreira, T. Marysael, N. Rubio,
decoy inhibits tumor growth and lung metastasis by reversing the drawbacks M. Firczuk, C. Mathieu, A. J. Roebroek, W. Annaert, J. Golab, P. de Witte, P. Vandenabeele,
of sonodynamic therapy. Adv. Healthc. Mater. 9, 1901335 (2020). P. Agostinis, A novel pathway combining calreticulin exposure and ATP secretion
12. L. Zitvogel, O. Kepp, G. Kroemer, Decoding cell death signals in inflammation in immunogenic cancer cell death. EMBO J. 31, 1062–1079 (2012).
and immunity. Cell 140, 798–804 (2010). 38. J. Fucikova, P. Kralikova, A. Fialova, T. Brtnicky, L. Rob, J. Bartunkova, R. Spísek, Human
13. A. M. Dudek, A. D. Garg, D. V. Krysko, D. De Ruysscher, P. Agostinis, Inducers tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res.
of immunogenic cancer cell death. Cytokine Growth Factor Rev. 24, 319–333 (2013). 71, 4821–4833 (2011).
Wang et al., Sci. Adv. 2021; 7 : eabj4796 20 October 2021 14 of 15